Medical Marijuana, Inc.

History

In 2009 Vivanet changed its name to Medical Marijuana, Inc. and became the first publicly traded company in the cannabis industry. It has been described as a holding company for businesses that provides products, services and security relating to the cannabis industry. The company has steadily grown it's portfolio of subsidiaries to broaden their reach from customer products to research and development. Additionally, the company services include a licensing division that manages proprietary testing, genetics, labelling, packaging, tracking, production, and standardization methods for the medicinal hemp industry.

In the fall of 2014, the company filed a lawsuit against Project CBD and Stewart Environmental labs to dispute a report of “significant levels of toxic solvents” in the hemp oil offered by one of their subsidiaries. Stewart Environmental settled with the company but Project CBD filed an anti-SLAPP motion in May 2015.

In January 2015, Medical Marijuana Inc. acquired the hemp and marijuana marketing company, Kannaway, and its subsidiary, Dixie Botanicals, for an undisclosed amount.

In May 2015, Medical Marijuana Inc. became the first American company to secure an export agreement through Brazil's National Sanitary Surveillance Agency (ANVISA) for their product, Real Scientific Hemp Oil™. The changes in law were enacted to assist in relieving the onset of seizures in two adolescent patients in Brazil. The historic move by the Brazilian government was met with positive reception by the scientific community and members of the public alike. The company's CEO, Dr. Stuart Titus referred to the Brazilian government's decisions as commendable for, "responding to the humanitarian interests of its people by allowing them access to CBD hemp oil products that can treat the symptoms of conditions with no known cure or limited treatment options."

Prominent Subsidiaries & Investments

Medical Marijuana Inc. has a wide ranging portfolio of subsidiaries generally related to services in the greater cannabis industry. The products of the various subsidiaries range from patented and proprietary based cannabinoid products, to extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. The services related to the company's portfolio development of cannabinoid based health and wellness products, and the development of medical grade compounds.

HempMeds

HempMeds serves as the primary means of the company's sale of hemp based consumer products. HempMeds was founded in 2012 as a subsidiary of Medical Marijuana inc. The company stands as one of the largest distributors and marketers of cannabinoid products in the United States.

HempMeds Mexico

HempMeds Mexico is the distribution branch for Medical Marijuana Inc.'s products in Mexico. The focus of the subsidiary is to provide non-psychoactive cannabidiol products to the Mexican public. HempMeds Mexico was the first company to provide a medical cannabis product approved by the Mexican government for import. In 2016, the Mexican health authority COFEPRIS granted permission for the company to begin usage of HempMeds flagship product, RSHO-X to be used for pain associated with cancer treatment in the country. The initial permits granted by the Mexican government have enabled access for over 126 million individuals in Mexico. Despite some initial reluctance by the Mexican government, HempMeds Mexico created a completely free THC product that was approved in the country.

HempMeds Brasil

HempMeds Brasil is the distribution branch for Medical Marijuana Inc.'s products within Brazil. Through HempMeds Brasil the company has educated, organized, and supported families in need of CBD hemp oil products for medicinal purposes. In 2014, the company became the first company to offer legal medical cannabis products in Brazil. The decision was ushered in after a a family won a courtroom battle to legally use the HempMeds product to assist their daughter who was suffering from a form of epilepsy. In 2015, Brazil's national health agency granted for importation of HempMeds CBD hemp oil product for import into the country. The case of a 6 year old adolescent girl named Anna Fischer served as one of the major factors leading to the legalization of the company's cannabis products in Brazil. Fischer, who suffered from constant seizures was part of the case leading to a historic ruling that removed non-psychoactive cannabidiol entirely from Brazil's list of prohibited substances.

Kannaway

Kannaway is a network sales and marketing company specializing in hemp based botanical products. In 2015, Kannaway became the newest portfolio acquisitions by Medical Marijuana Inc. The products of Kannaway range form skin care to energy chews.

AXIM Biotech

Medical Marijuana Inc. stands as a major investor for the biotechnology company, Axim Biotech. Axim Biotech is a biotechnology company focused on research, development, and production of pharmaceutical, nutraceutical, and cosmetic products as well as alternative energy resource. The company is dedicated towards s a low cost approach to the development of pharmaceutical by focusing on cannabinoid compounds. The company has begun clinical trials on treatment for such disorders as Irritable Bowel Syndrome (IBS). The CEO for the company is Dr. George Anasassov.

Notable Media Appearances

In March 2014, Medical Marijuana Inc. was featured in a documentary titled, "Illegal" that profiled the case of Anna Fischer and her fight to receive non psychoactive cannabidiol to treat the symptoms of her recurring seizures.

In May 2016, Medical Marijuana Inc. was featured prominently in a documentary, Crisis detailing the legal struggle parents faced in Mexico as they attempted to gain access to CBD hemp oil products for their ailing children. The company, its subsidiaries, and CEO have been featured in national and international press outlets including Forbes and Fox.